Tehran (IP) - Top Adviser to the Leader of the Islamic Revolution for International Affairs said Shahid Beheshti University managed to produce Favipiravir medicine.

Iran Press/Iran news: Top Adviser to the Leader of the Islamic Revolution for International Affairs Ali Akbar Velayati said on Sunday 5 April that Favipiravir medicine received an ethics committee approval and after observing legal procedures was sent to Massih Daneshvari Hospital to treat COVID-19 disease patients.

He asserted that Massih Daneshvari Hospital receives no money for treating the coronavirus infected patients and provides them with full service.

Velayati who has recovered from COVID-19 attended the first meeting of the scientific council of the hospital in the new Iranian year and appreciated the hard work of the health center staff who are fighting at the forefront of fighting Coronavirus.

104/219

Read More:

Number of Iran's COVID-19 recovered patients nears 20,000

Nearly 18,000 Iranian COVID-19 patients recovered

Iran's COVID-19 latest statistics; 16711 recovered

15473 Iranian patients recovered from COVID-19

Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19
Iranian researchers produce Favipiravir to treat COVID-19